MoneyWorks4Me

Tavexia Lifecare shines on expanding into pharmaceutical business

26 Aug 2026 Evaluate

Tavexia Lifecare is currently trading at Rs. 1.05, up by 0.17 points or 19.32% from its previous closing of Rs. 0.88 on the BSE.

The scrip opened at Rs. 0.92 and has touched a high and low of Rs. 1.05 and Rs. 0.92 respectively. So far 6076459 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 1.05 on 26-Aug-2026 and a 52 week low of Rs. 0.49 on 04-Dec-2025.

Last one week high and low of the scrip stood at Rs. 1.05 and Rs. 0.74 respectively. The current market cap of the company is Rs. 40.28 crore.

The promoters holding in the company stood at 6.39%, while non-institutions held 93.61% stake in the company.

Tavexia Lifecare has expanded into the pharmaceutical business as an additional growth vertical, strengthening its broader presence in the healthcare and lifecare ecosystem. The move forms part of the company’s growth and diversification strategy while its existing lifecare business remains at the core of its operations.

The company plans to explore opportunities across the pharmaceutical value chain, including pharmaceutical products, active pharmaceutical ingredients (APIs), intermediates, specialty chemicals, nutraceuticals and related manufacturing opportunities. The new vertical is intended to complement Tavexia’s existing lifecare operations and provide additional avenues for business expansion.

Tavexia Lifecare (formerly known as Sattva Sukun Lifecare) is engaged in manufacturing & trading of Burners.

Tavexia Lifecare Share Price

1.01 -0.02 (-1.94%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 365.85
Amrapali Industries 33.14
Adani Enterprises 3166.00
Rashi Peripheral 829.70
PDS 369.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: